<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141290">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01981083</url>
  </required_header>
  <id_info>
    <org_study_id>217B500602013026</org_study_id>
    <nct_id>NCT01981083</nct_id>
  </id_info>
  <brief_title>Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients</brief_title>
  <official_title>Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Lic Adolfo Lopez Mate</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Medico Lic Adolfo Lopez Mate</source>
  <oversight_info>
    <authority>Mexico: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is seen frequently in hemodialysis units in most developing countries.
      Malnutrition increases morbidity and mortality in this population and its treatment improves
      patient survival and health status The purpose of this study is to compare two strategies to
      improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml)
      versus egg albumin-based protein supplement (30 g) on a daily basis.

      This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment
      (SGA) in addition to most used biochemical markers to determine nutritional status.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Malnutrition-Inflammation Score</measure>
    <time_frame>Bimonthly, up to six months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Subjective Global Assessment</measure>
    <time_frame>Bimonthly, up to six months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Protein-Energy Malnutrition</condition>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Egg albumin-based protein supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powder form, dosage 30 g daily, duration 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Renal-specific oral supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liquid form, dosage 237 ml (one can) daily, duration 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Egg albumin-based protein supplement</intervention_name>
    <arm_group_label>Egg albumin-based protein supplement</arm_group_label>
    <other_name>Pure ProEgg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Renal-specific oral supplement</intervention_name>
    <arm_group_label>Renal-specific oral supplement</arm_group_label>
    <other_name>Enterex Renal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Kidney Disease in Hemodialysis

        Exclusion Criteria:

          -  Infection

          -  Liver insufficiency

          -  Cancer or neoplasia

          -  Acquired immunodeficiency syndrome

          -  Intestinal malabsorption syndrome
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rafael Gonzalez-Toledo, MD</last_name>
    <phone>52(722)2760860</phone>
    <phone_ext>90457</phone_ext>
    <email>rtoledo29@yahoo.com.mx</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro Medico Lic. Adolfo LÃ³pez Mateos</name>
      <address>
        <city>Toluca</city>
        <state>Estado de Mexico</state>
        <zip>50010</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rafael Gonzalez-Toledo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 5, 2013</lastchanged_date>
  <firstreceived_date>October 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Medico Lic Adolfo Lopez Mate</investigator_affiliation>
    <investigator_full_name>Rafael Gonzalez-Toledo</investigator_full_name>
    <investigator_title>Affiliated Physician of the Nephrology Service</investigator_title>
  </responsible_party>
  <keyword>Protein-Energy Malnutrition</keyword>
  <keyword>Chronic Kidney Disease</keyword>
  <keyword>Malnutrition-Inflammation Score</keyword>
  <keyword>Subjective Global Assessment</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Egg albumin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Protein-Energy Malnutrition</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
